Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Medtronic
McKesson
Baxter
Argus Health
McKinsey
Cerilliant
AstraZeneca
US Army
Moodys

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,497,256

« Back to Dashboard

Which drugs does patent 8,497,256 protect, and when does it expire?

Patent 8,497,256 protects GIAZO and is included in one NDA.

This patent has nine patent family members in eight countries.
Summary for Patent: 8,497,256
Title:Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
Abstract: The instant application provides methods and compositions for the treatment of male subjects having ulcerative colitis.
Inventor(s): Forbes; William (Raleigh, NC), Bortey; Enoch (Chapel Hill, NC), Johnson; Lorin (Palo Alto, CA)
Assignee: Salix Pharmaceuticals, Ltd (Raleigh, NC)
Application Number:13/094,261
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 8,497,256

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Valeant Pharms Intl GIAZO balsalazide disodium TABLET;ORAL 022205-001 Feb 3, 2012 AB RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,497,256

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011245455 ➤ Subscribe
Brazil 112012027520 ➤ Subscribe
Brazil 122014009845 ➤ Subscribe
Canada 2797560 ➤ Subscribe
European Patent Office 2563117 ➤ Subscribe
Israel 222642 ➤ Subscribe
Japan 2013525440 ➤ Subscribe
Mexico 2012012324 ➤ Subscribe
World Intellectual Property Organization (WIPO) 2011137103 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
Fish and Richardson
Accenture
US Army
Express Scripts
Covington
Cantor Fitzgerald
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot